These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20004096)

  • 1. Identification of a new class of small molecule C5a receptor antagonists.
    Chen JJ; Cole DC; Ciszewski G; Crouse K; Ellingboe JW; Nowak P; Tawa GJ; Berstein G; Li W
    Bioorg Med Chem Lett; 2010 Jan; 20(2):662-4. PubMed ID: 20004096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of C5a-C5aR interaction in sepsis.
    Guo RF; Riedemann NC; Ward PA
    Shock; 2004 Jan; 21(1):1-7. PubMed ID: 14676676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
    Nikiforovich GV; Marshall GR; Baranski TJ
    Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung.
    Haviland DL; McCoy RL; Whitehead WT; Akama H; Molmenti EP; Brown A; Haviland JC; Parks WC; Perlmutter DH; Wetsel RA
    J Immunol; 1995 Feb; 154(4):1861-9. PubMed ID: 7836770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
    March DR; Proctor LM; Stoermer MJ; Sbaglia R; Abbenante G; Reid RC; Woodruff TM; Wadi K; Paczkowski N; Tyndall JD; Taylor SM; Fairlie DP
    Mol Pharmacol; 2004 Apr; 65(4):868-79. PubMed ID: 15044616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
    Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
    J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist.
    Bao L; Osawe I; Puri T; Lambris JD; Haas M; Quigg RJ
    Eur J Immunol; 2005 Aug; 35(8):2496-506. PubMed ID: 16052609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C5a receptor antagonists for the treatment of inflammation.
    Sumichika H
    Curr Opin Investig Drugs; 2004 May; 5(5):505-10. PubMed ID: 15202723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
    Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
    Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonistic peptides against human anaphylatoxin C5a.
    Kaneko Y; Okada N; Baranyi L; Azuma T; Okada H
    Immunology; 1995 Sep; 86(1):149-54. PubMed ID: 7590876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor.
    Tardif M; Brouchon L; Rabiet MJ; Boulay F
    Biochem J; 2003 Jun; 372(Pt 2):453-63. PubMed ID: 12600272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
    Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
    J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
    Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
    J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weak response of porcine C5a receptor towards human C5a in miniature pig endothelial cells and PMNs.
    Yi KS; Lee S; Kang YH; Bae YS; Hwang SY; Ha I; Kim H; Kim MS; Cho B; Kang HJ; Bang KT; Kim JY; Yang J; Chung J; Ahn C
    Xenotransplantation; 2007 Nov; 14(6):563-71. PubMed ID: 17991144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
    J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of C5a receptor gene with siRNA for protection from Gram-negative bacterial lipopolysaccharide-induced vascular permeability.
    Liu ZM; Zhu SM; Qin XJ; Cheng ZD; Liu MY; Zhang HM; Liu DX
    Mol Immunol; 2010 Mar; 47(6):1325-33. PubMed ID: 20138669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional identification of the stable transfection C5aR cell line Molt-4.
    Zhang C; Xu R; Wang J; Han G; Chen G; Wang R; Wei H; Shen B; Ma Y; Li Y
    Cell Mol Immunol; 2007 Dec; 4(6):461-5. PubMed ID: 18163958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the C5a receptor promoter in glial cells: Minimal dependence upon the CCAAT element in astrocytes.
    Martin CB; Ingersoll SA; Martin BK
    Mol Immunol; 2007 Feb; 44(5):713-21. PubMed ID: 16750856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel interpretation of immune redundancy and duality in reperfusion injury with important implications for intervention in ischaemic disease.
    Thrane AS; Skehan JD; Thrane PS
    Med Hypotheses; 2007; 68(6):1363-70. PubMed ID: 17169498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.